I was disappointed in the public offer price of $4. Trading volume was good on the first night but it ended below the offer price, also a bit disappointed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025